Changes

Jump to navigation Jump to search

ICRP Glossary

2,921 bytes added, 22:10, 24 February 2021
no edit summary
Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications.
The ICRP Glossary shown here comprises some 400 terms. Entries for an additional approximately 400 terms are being prepared, and will be added here in due courseprogressively.
----
{| class="wikitable"
|-
| [[#A|A]] || [[#B|B]] || [[#C|C]]|| [[#D|D]] || [[#E|E]] || [[#F|F]] || [[#G|G]] || [[#H|H]] || [[#I|I]] || [[#J|J]] || [[#K|K]] || [[#L|L]] || [[#M|M]] ||[[#N|N]] || [[#O|O]] || [[#P|P]] || [[#Q|Q]] || [[#R|R]] || [[#S|S]] || [[#T|T]] || [[#U|U]] || [[#V|V]] || [[#W|W]] || [[#X|X]] || [[#Y|Y]] || [[#Z|Z]] || [[#ZZ|...]]
|}
=== <big><span id="A">A</span></big> ===
* [[Accelerated fractionationAbsolute risk]]
* [[Acceptance testAccelerated fractionation]]
* [[Access ControlAcceptance test]]
*[[Access control]] * [[Accountability]]
*[[Action Level]]
*[[Active (red) bone marrow]]
*[[Activity median thermodynamic diameter ]] *[[Acute exposure]] *Acute radiation sickness (see *[[Acute radiation syndrome]])
*[[Acute Exposureradiation syndrome]] *[[Adaptive response]] *[[Additive risk projection model]]
*[[Adventitious]]
*[[Adventitious Sourcesource]]
*[[Aerodynamic diameter ]]
*[[Alpha decay]]
 
*[[α/β ratio]]
*[[Alveolar-interstitial region]]
*[[Area monitoring]]
 
*ARS (see [[Acute radiation syndrome]])
 
*[[Attributable risk]]
*[[Auger transition]]
*[[Authorised Dischargedischarge]]
*[[Authorization]]
*[[Background dose (rate)]]
*[[Backscatter Factor factor]]
*[[Basal cell]]
 
*[[Baseline disease rates]]
 
*BAT (see [[Best available techniques]])
*[[Beneficence]]
*[[Benthic]]
*[[Best Available Techniquesavailable techniques]]
*[[Beta-minus decay]]
*[[Bioassay]]
 
*[[Biomarker]]
*[[Biomedical research volunteer]]
*[[Cardioverter-defibrillator]]
 
*[[Case–control study]]
*[[Cell death]]
*[[Co-expertise]]
 
*[[Cohort study]]
*[[Colony]]
=== <big><span id="D">D</span></big> ===
 
*DD (see [[Doubling dose)]])
 
*DDREF (see [[Dose and dose-rate effectiveness factor)]])
*[[Decay constant]]
*[[Deontological Ethics]]
 
*[[Deterministic effect]]
 
*Detriment (see [[Radiation detriment]])
 
*[[Detriment-adjusted risk]]
*[[Diastasis]]
 
*[[Dicentric chromosome]]
*[[Dichotomous]]
*[[Disposal]]
*[[Disposal Facilityfacility]]
*[[DNA damage signalling]]
 
*[[Dose and dose-rate effectiveness factor)]]
*[[Dose constraint]]
*[[Dose limit]]
*[[Dose Modifying Factormodifying factor]]
*[[Dose per unit intake coefficient]]
*[[Dose rate effectiveness factor]]
 
*[[Dose-threshold hypothesis]]
*[[Dose-rate effect]]
*[[Dose-threshold]]
 
*[[Doubling dose]]
=== <big><span id="E">E</span></big> ===
*[[Effect Dose 50 ]]
 
*[[Effect modifier]]
*[[Effective charge number]]
*[[Electrophysiology]]
 
*[[Elemental dose]]
 
*ELR (see *[[Excess lifetime risk]])
*[[Emergency]]
*[[Endogeneous excretion]]
 
*[[Epigenetic effects]]
*[[Environmental exposure]]
*[[Ethics]]
 
*[[Excess absolute risk]]
 
*[[Excess lifetime risk]]
 
*[[Excess relative risk]]
*[[Excretion rate (instantaneous)]]
*[[Exposure, external or internal]]
*[[Exposure Pathwaypathway]]
*[[Exposure situation]]
*[[Gastrointestinal syndrome]]
 
*[[Genomic integrity]]
*[[Graded approach]]
*[[Heliosphere]]
 
*[[Hereditary effect]]
*[[Hierarchical tissues]]
*[[High level waste]]
 
*[[Homologous recombination]]
*[[Hormones]]
*[[In vivo radiobioassay]]
 
*[[Incidence]]
 
*Incidence rate (see [[Incidence]])
*[[Incident]]
*[[Individual-related]]
*[[Induced genomic instability]] *[[Informed Consentconsent]]
*[[Inhalability]]
=== <big><span id="L">L</span></big> ===
*[[Late normal tissue responses]]
*[[Latent time/period or latency interval]]
 
*[[LD 50/30|LD<sub>50/30</sub>]]
 
*[[Life span study]]
 
*[[Lifetime risk]]
 
*[[Lifetime risk estimate]]
*[[Limitation of dose]]
*[[Lineal energy]]
 
*[[Linear dose response]]
*[[Linear-non-threshold model]]
 
*[[Linear-quadratic dose response]]
 
*LLE (see [[Loss of Life Expectancy]])
 
*[[Loss of Life Expectancy]]
*[[Low Earth orbit]]
 
*[[Low dose]]
 
*[[Low dose rate]]
*[[Low level waste]]
 
*LSS (see [[Life span study]])
*[[Lymphatic system]]
=== <big><span id="M">M</span></big> ===
 
*[[Macrophage colony stimulating factor]]
*[[Mitigation]]
 
*[[Multiplicative risk projection model]]
 
*[[Multistage carcinogenesis model]]
*[[Multistage tumorigenesis]]
 
*[[Mutation component]]
*[[Myocardial perfusion]]
*[[Neurovascular syndrome]]
 
*NHEJ (see [[Non-homologous end joining]])
 
*[[Nominal risk coefficient]]
 
*[[Non-homologous end joining]]
*[[Non-maleficence]]
*[[Non-sphericity parameter]]
 
*[[Non-targeted effects]]
 
*[[Normal tissue complication probability]]
*[[Nuclear track detectors]]
=== <big><span id="O">O</span></big> ===
*[[Occupational exposure]]
*[[Occupational exposureOncogene]]
*[[Optimisation]]
*[[Platelet-derived growth factor]]
 
*PLDR (see [[Potentially lethal damage repair]])
 
*[[Pooled analysis]]
 
*[[Population risk]]
*[[Potential exposure]]
 
*[[Potentially lethal damage repair]]
*[[Practical radiological protection culture]]
=== <big><span id="Q">Q</span></big> ===
*[[Qualified expert]]
*[[Qualified expertQuasi-threshold dose]]
=== <big><span id="R">R</span></big> ===
*[[Radiation modifier]]
 
*[[Radiation risk]]
*[[Radiation safety officer]]
*[[Radiographer]]
*[[Radiological Controlled Areacontrolled area]]
*[[Radiological protection principles]]
*[[Radiosensitivity, cellular]]
 
*RAP (see [[Reference Animal and Plant]])
 
*RBE (see [[Relative biological effectiveness]])
 
*[[Reactive oxygen species]]
*[[Reasonableness]]
*[[Recovery responder]]
 
*[[Recovery (cellular or tissue)]]
 
*[[Reference Animal and Plant]]
*[[Reference bioassay function]]
*[[Reference level]]
 
*REID (see [[Risk of exposure-induced death]])
*[[Rehabilitation of living conditions]]
 
*[[Relative biological effectiveness]]
 
*[[Relative life lost]]
 
*[[Relative risk]]
*[[Relocation]]
*[[Rigidity]]
 
*[[Ring chromosome]]
 
*[[Risk]]
 
*[[Risk coefficient]]
 
*[[Risk model]]
 
*[[Risk of exposure-induced death]]
 
*ROS (see [[Reactive oxygen species]])
*[[Routine monitoring]]
 
*RR (see [[Relative risk]])
=== <big><span id="S">S</span></big> ===
*[[Senescence]]
 
*[[Severe deterministic injury]]
 
*SLDR (see [[Sublethal damage repair]])
*[[Slow repair]]
*[[Solar wind]]
 
*[[Somatic effect]]
*[[Source term]]
*[[Stenosis]]
 
*[[Stochastic effect]]
*[[Storage]]
*[[Subcutaneous tissue]]
 
*[[Sublethal damage repair]]
*[[Substantial radiation dose level]]
*[[Supervised Areaarea]]
*[[Systemic model]]
*[[Target tissue]]
 
*[[Targeted effects]]
*[[Telangiectasia]]
*[[Tissue equivalent material]]
 
*[[Tissue reaction]]
 
*[[Tissue weighting factor]]
*[[Tolerability]]
*[[Transfer compartment]]
 
*[[Transfer of risk]]
*[[Transfer rate]]
*[[Transforming growth factor]]
 
*[[Transgenerational effect]]
 
*[[Translocation]]
*[[Transparency]]
 
*Transport of risk (see [[Transfer of risk]])
 
*[[Tumour suppressor gene]]
*[[Trapped particles]]
=== <big><span id="U">U</span></big> ===
 
*[[Unsealed source]]
=== <big><span id="V">V</span></big> ===
 
*[[Value judgement]]
*[[Wisdom]]
 
*w<sub>T</sub> (see [[Tissue weighting factor]])
 
*w<sub>R</sub> (see [[Radiation weighting factor]])
=== <big><span id="X">X</span></big> ===
=== <big><span id="Z">Z</span></big> ===
 
=== <big><span id="ZZ">...</span></big> ===
 
 
*[[α/β value]]
 
*α/β ratio (see [[α/β value]])
 
*[[γH2AX foci]]
<div>

Navigation menu